Safety and Tolerability of 3 CGRP Monoclonal Antibodies in Practice: A Retrospective Cohort Study.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Safety and Tolerability of 3 CGRP Monoclonal Antibodies in Practice: A Retrospective Cohort Study.
- Published In:
- Headache, 60(10), 2454-2462 (2020)
- Authors:
- Alex, Ashley, Vaughn, Caila, Rayhill, Melissa
- Database ID:
- RPEP-04629
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04629APA
Alex, Ashley; Vaughn, Caila; Rayhill, Melissa. (2020). Safety and Tolerability of 3 CGRP Monoclonal Antibodies in Practice: A Retrospective Cohort Study.. Headache, 60(10), 2454-2462. https://doi.org/10.1111/head.13956
MLA
Alex, Ashley, et al. "Safety and Tolerability of 3 CGRP Monoclonal Antibodies in Practice: A Retrospective Cohort Study.." Headache, 2020. https://doi.org/10.1111/head.13956
RethinkPeptides
RethinkPeptides Research Database. "Safety and Tolerability of 3 CGRP Monoclonal Antibodies in P..." RPEP-04629. Retrieved from https://rethinkpeptides.com/research/alex-2020-safety-and-tolerability-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.